|
|
|
Volumn 1, Issue SUPPL. 1, 1998, Pages
|
|
Tolerability profiles of AChEIs: A critical component of care for Alzheimer's disease patients
|
|
Author keywords
Acetylcholinesterase inhibitors; Alzheimer's disease; Bridging studies; Dose optimization; Safety; Tolerability
|
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
MECLOZINE;
PHYSOSTIGMINE;
PLACEBO;
RIVASTIGMINE;
TACRINE;
TRIHEXYPHENIDYL;
AGED;
ALZHEIMER DISEASE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMENTIA;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
GASTROINTESTINAL SYMPTOM;
GERONTOPSYCHIATRY;
HUMAN;
INSOMNIA;
MAJOR CLINICAL STUDY;
MUSCLE CRAMP;
NAUSEA;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VOMITING;
|
|
EID: 0031646338
PISSN: 13648233
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (46)
|
